national cancer institute
Patients with severe type of muscular dystrophy at increased risk of cancer
Compared to the general population, patients with myotonic muscular dystrophy (MMD; a form of muscular dystrophy marked by generalized weakness and muscular wasting that affects the face, feet, hands and neck) are at increased risk of canc…
Scientists develop vaccine that successfully attacks breast cancer in mice
Researchers at Mayo Clinic in Arizona (http://www.mayoclinic.org/arizona/) and the University of Georgia (UGA) have developed a vaccine that dramatically reduces tumors in a mouse model that mimics 90 percent of human breast and …
Family or no, marrow, blood stem cell transplant survival rates equal
Patients who receive a blood stem cell transplant from a donor outside of their family to treat leukemia and other blood diseases are more likely to have graft failure but less likely to experience graft-versus-host disease, a condition caused…
Researchers identify genetic mutation responsible for rare cancer
Scientists at Dana-Farber Cancer Institute have identified a gene mutation that underlies the vast majority of cases of Waldenstrom’s macroglobulinemia, a rare form of lymphoma that has eluded all previous efforts to find a genetic cause.
…
B cell receptor inhibitor causes chronic lymphocytic leukemia remission
A new, targeted approach to treating chronic lymphocytic leukemia has produced durable remissions in a Phase I/II clinical trial for patients with relapsed or resistant disease, investigators report at the 53rd Annual Meeting of the America…
Breast cancer patients face increasing number of imaging visits before surgery
Breast cancer patients frequently undergo imaging like mammograms or ultrasounds between their first breast cancer-related doctor visit and surgery to remove the tumor. Evaluations of these scans help physicians understand a person’s…
Unique genetic marker may improve detection of recurrent ovarian cancer
Ovarian cancer is a major health concern for women and the identification of sensitive biomarkers for early detection and/or monitoring of disease recurrence is of high clinical relevance.
New work published in the Dec. 7 issue of the online journal P…
Rare gene variants critical for personalized drug treatment
The use of genetic tests to predict a patient’s response to drugs is increasingly important in the development of personalized medicine. But genetic tests often only look for the most common gene variants. In a pharmacogenomics …